Filtros de búsqueda

Lista de obras de

A Combination of Approved Antibodies Overcomes Resistance of Lung Cancer to Osimertinib by Blocking Bypass Pathways

artículo científico publicado en 2018

A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy

A functional interaction between CHIF and Na-K-ATPase: implication for regulation by FXYD proteins

scientific article published on 01 October 2002

A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors.

artículo científico publicado en 2016

A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration

artículo científico publicado en 2007

A specific functional interaction between CHIF and Na,K-ATPase: role of FXYD proteins in the cellular regulation of the pump

artículo científico publicado en 2003

AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer

scientific article published on 07 February 2019

An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors

artículo científico publicado en 2017

Bortezomib-induced pro-inflammatory macrophages as a potential factor limiting anti-tumour efficacy

artículo científico publicado en 2016

Combining three antibodies nullifies feedback-mediated resistance to erlotinib in lung cancer

artículo científico publicado en 2015

Covalent cross-links between the gamma subunit (FXYD2) and alpha and beta subunits of Na,K-ATPase: modeling the alpha-gamma interaction

artículo científico publicado en 2005

Database-independent Protein Sequencing (DiPS) Enables Full-length de Novo Protein and Antibody Sequence Determination

artículo científico publicado en 2017

Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment

artículo científico publicado en 2014

Domains involved in the interactions between FXYD and Na,K-ATPase

artículo científico publicado en 2003

Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3.

artículo científico publicado en 2015

Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone

artículo científico publicado en 2017

Examination of HER3 targeting in cancer using monoclonal antibodies

artículo científico publicado en 2015

Functional interactions of phospholemman (PLM) (FXYD1) with Na+,K+-ATPase. Purification of alpha1/beta1/PLM complexes expressed in Pichia pastoris

artículo científico publicado en 2006

Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR.

artículo científico publicado en 2013

Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors

artículo científico publicado en 2022

SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors.

artículo científico publicado en 2018

Structural interactions between FXYD proteins and Na+,K+-ATPase: alpha/beta/FXYD subunit stoichiometry and cross-linking

scientific journal article

Structure-function relations of interactions between Na,K-ATPase, the gamma subunit, and corticosteroid hormone-induced factor

scientific journal article

Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer

artículo científico publicado en 2015

Tailored cancer immunotherapy using combinations of chemotherapy and a mixture of antibodies against EGF-receptor ligands

artículo científico publicado en 2010

Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor

scientific article published on 24 August 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda